RoActemra 80 mg/4 ml
RoActemra 80 mg/4 ml is a prescription medicine containing tocilizumab, a biologic medicine used to treat certain inflammatory and autoimmune conditions. It is supplied as a concentrate for solution for infusion and must be administered by a qualified healthcare professional.
What Is It Used For?
RoActemra may be prescribed for rheumatoid arthritis, certain forms of juvenile idiopathic arthritis, giant cell arteritis, and specific cases of cytokine release syndrome. In some circumstances, it is also used for COVID-19 in hospitalised adults who require oxygen or respiratory support. Approved uses vary by country.
Active Ingredient
Tocilizumab — 80 mg per 4 ml vial (20 mg/ml).
Administration
The concentrate must be diluted and given by intravenous infusion by a qualified healthcare professional. The dose and schedule depend on the condition being treated and the patient’s individual circumstances.
Possible Side Effects
Possible side effects include upper respiratory infections, headache, high blood pressure, changes in liver enzymes or cholesterol, and infusion reactions. Serious risks include severe infections, liver injury and, rarely, gastrointestinal perforation.
Warnings and Precautions
Tell your doctor about current or recurring infections, tuberculosis exposure, liver disease and other medicines you take. Blood tests may be required to monitor blood cell counts, liver function and cholesterol. Seek medical advice promptly if you develop signs of a serious infection.
Storage
Store refrigerated at 2–8°C. Do not freeze. Keep the vial in its outer carton to protect it from light, and keep it out of the reach of children.
RoActemra 80 mg/4 ml is a prescription biologic medicine containing tocilizumab, used for selected inflammatory and autoimmune conditions. It requires professional administration, appropriate laboratory monitoring and medical supervision because of the risk of serious side effects.
https://pharmatoo.com/product-category/pharmacy/the-immune-system/
Tags
RoActemra 80 mg/4 ml
RoActemra
tocilizumab
rheumatoid arthritis
autoimmune diseases
biologic medicine
anti-inflammatory treatment
intravenous infusion
prescription medicine
medication safety
